Araştırma Makalesi
BibTex RIS Kaynak Göster
Yıl 2021, Cilt: 4 Sayı: 5, 722 - 727, 05.09.2021
https://doi.org/10.32322/jhsm.957308

Öz

Kaynakça

  • Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. lancet 2020; 395: 497-506.
  • Chan JF-W, Yuan S, Kok K-H, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet 2020; 395: 514-23.
  • Wang C, Horby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of global health concern. Lancet 2020; 395: 470-3.
  • Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia. N Engl J Med 2020.
  • Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020; 395: 507-13.
  • Wei X, Xiao Y-T, Wang J, et al. Sex differences in severity and mortality among patients with COVID-19: evidence from pooled literature analysis and insights from integrated bioinformatic analysis. arXiv 200313547. 2020.
  • Zheng Z, Peng F, Xu B, et al. Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis. J Infect 2020; 81: e16-e25.
  • Sohrabi C, Alsafi Z, O’Neill N, et al. World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19). Int J Surg 2020; 76: 71-6.
  • Jeyanathan M, Afkhami S, Smaill F, Miller MS, Lichty BD, Xing Z. Immunological considerations for COVID-19 vaccine strategies. Nat Rev Immunol 2020; 20: 615-32.
  • Garcia-Perez MA, Nunez-Anton V. Cellwise residual analysis in two-way contingency tables. Educ Psychol Meas 2003; 63: 825-39.
  • Cucinotta D, Vanelli M. WHO declares COVID-19 a pandemic. Acta Biomed Ateneo Parmense 2020; 91: 157-60.
  • Fehr AR, Perlman S. Coronaviruses: an overview of their replication and pathogenesis. Coronaviruses: Springer; 2015. p. 1-23.
  • Cosby AG, McDoom-Echebiri MM, James W, Khandekar H, Brown W, Hanna HL. Growth and persistence of place-based mortality in the United States: the rural mortality penalty. Am J Public Health 2019; 109: 155-62.
  • Kirakli C, Tatar D, Cimen P, et al. Survival from severe pandemic H1N1 in urban and rural Turkey: a case series. Respir care 2011; 56: 790-5.
  • Sharma G, Volgman AS, Michos ED. Sex differences in mortality from COVID-19 pandemic: are men vulnerable and women protected?. JACC Case Rep 2020; 2: 1407-10.
  • Fang L, Karakiulakis G, Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Resp Med 2020; 8: e21.
  • Johnston SL. Asthma and COVID-19: Is asthma a risk factor for severe outcomes?. Allergy 2020; 75: 1543-5.
  • Mehra MR, Ruschitzka F. COVID-19 Illness and Heart Failure: A Missing Link?. JACC Heart Fail 2020; 8: 512-4.
  • Alqahtani JS, Oyelade T, Aldhahir AM, et al. Prevalence, severity and mortality associated with COPD and smoking in patients with COVID-19: a rapid systematic review and meta-analysis. PLoS one. 2020; 15: e0233147.
  • Moghadas SM, Fitzpatrick MC, Sah P, et al. The implications of silent transmission for the control of COVID-19 outbreaks. Proc Natl Acad Sci 2020; 117: 17513-5.
  • Bernheim A, Mei X, Huang M, et al. Chest CT findings in coronavirus disease-19 (COVID-19): relationship to duration of infection. Radiology 2020: 200463.
  • Rodriguez-Leor O, Cid-Alvarez B. ST-Segment Elevation Myocardial Infarction Care During COVID-19: Losing Sight of the Forest for the Trees. JACC Case Rep 2020; 2: 1625-7.
  • Khafaie MA, Rahim F. Cross-country comparison of case fatality rates of COVID-19/SARS-COV-2. Osong Public Health Res Perspect 2020; 11: 74.
  • Öztoprak F, Javed A. Case fatality rate estimation of COVID-19 for European countries: Turkey’s current scenario amidst a global pandemic; comparison of outbreaks with European countries. EJMO 2020; 4: 149-59

The impact of COVID-19 on rural population: A retrospective study

Yıl 2021, Cilt: 4 Sayı: 5, 722 - 727, 05.09.2021
https://doi.org/10.32322/jhsm.957308

Öz

Objective: The COVID-19 outbreak became a major global health concern. There are some differences between urban and rural areas that may determine the impact of a viral pandemic. In our study, we aimed to investigate and present epidemiological, demographic, clinical, and radiological data relating to a rural area.
Materials and Methods: This retrospective two-center study involved 2234 patients tested for COVID-19 between March 30th and July 15th, 2020. All patients were analysed for clinical, demographic, and radiological data.
Results: Of the patients; 1309 (58.6%) were male, 925 (41.4%) female and 259 (11%) were PCR positive, and 1975 (89%) PCR negative. Of the PCR positive group, 121 (46.7%) were male and 138 (53.3%) female. The mean age was 38 ±18.5. Twenty-nine (11.2%) patients needed intensive care support. Twelve (4.6%) patients died due to COVID-19: two of them due to COVID-19-related myocardial infarction and ten of them due to severe pneumonia, acute respiratory distress syndrome (ARDS), multiorgan dysfunction, or septic shock. The case fatality rate (CFR) was 4.6%.
Conclusion: Age, sex, hypertension, diabetes, asthma, and heart failure were associated with COVID-19 infection. The risk of infection was higher in patients older than 20 years (p<0.001) and females (OR: 1.636; p<0.001). Patients with hypertension (OR: 2.281; p<0.001), diabetes (OR: 1.013; p=0.039), asthma (OR: 2.786; p=0.001) or heart failure (OR: 2.610; p=0.006) had a significantly higher risk of infection.

Kaynakça

  • Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. lancet 2020; 395: 497-506.
  • Chan JF-W, Yuan S, Kok K-H, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet 2020; 395: 514-23.
  • Wang C, Horby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of global health concern. Lancet 2020; 395: 470-3.
  • Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia. N Engl J Med 2020.
  • Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020; 395: 507-13.
  • Wei X, Xiao Y-T, Wang J, et al. Sex differences in severity and mortality among patients with COVID-19: evidence from pooled literature analysis and insights from integrated bioinformatic analysis. arXiv 200313547. 2020.
  • Zheng Z, Peng F, Xu B, et al. Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis. J Infect 2020; 81: e16-e25.
  • Sohrabi C, Alsafi Z, O’Neill N, et al. World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19). Int J Surg 2020; 76: 71-6.
  • Jeyanathan M, Afkhami S, Smaill F, Miller MS, Lichty BD, Xing Z. Immunological considerations for COVID-19 vaccine strategies. Nat Rev Immunol 2020; 20: 615-32.
  • Garcia-Perez MA, Nunez-Anton V. Cellwise residual analysis in two-way contingency tables. Educ Psychol Meas 2003; 63: 825-39.
  • Cucinotta D, Vanelli M. WHO declares COVID-19 a pandemic. Acta Biomed Ateneo Parmense 2020; 91: 157-60.
  • Fehr AR, Perlman S. Coronaviruses: an overview of their replication and pathogenesis. Coronaviruses: Springer; 2015. p. 1-23.
  • Cosby AG, McDoom-Echebiri MM, James W, Khandekar H, Brown W, Hanna HL. Growth and persistence of place-based mortality in the United States: the rural mortality penalty. Am J Public Health 2019; 109: 155-62.
  • Kirakli C, Tatar D, Cimen P, et al. Survival from severe pandemic H1N1 in urban and rural Turkey: a case series. Respir care 2011; 56: 790-5.
  • Sharma G, Volgman AS, Michos ED. Sex differences in mortality from COVID-19 pandemic: are men vulnerable and women protected?. JACC Case Rep 2020; 2: 1407-10.
  • Fang L, Karakiulakis G, Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Resp Med 2020; 8: e21.
  • Johnston SL. Asthma and COVID-19: Is asthma a risk factor for severe outcomes?. Allergy 2020; 75: 1543-5.
  • Mehra MR, Ruschitzka F. COVID-19 Illness and Heart Failure: A Missing Link?. JACC Heart Fail 2020; 8: 512-4.
  • Alqahtani JS, Oyelade T, Aldhahir AM, et al. Prevalence, severity and mortality associated with COPD and smoking in patients with COVID-19: a rapid systematic review and meta-analysis. PLoS one. 2020; 15: e0233147.
  • Moghadas SM, Fitzpatrick MC, Sah P, et al. The implications of silent transmission for the control of COVID-19 outbreaks. Proc Natl Acad Sci 2020; 117: 17513-5.
  • Bernheim A, Mei X, Huang M, et al. Chest CT findings in coronavirus disease-19 (COVID-19): relationship to duration of infection. Radiology 2020: 200463.
  • Rodriguez-Leor O, Cid-Alvarez B. ST-Segment Elevation Myocardial Infarction Care During COVID-19: Losing Sight of the Forest for the Trees. JACC Case Rep 2020; 2: 1625-7.
  • Khafaie MA, Rahim F. Cross-country comparison of case fatality rates of COVID-19/SARS-COV-2. Osong Public Health Res Perspect 2020; 11: 74.
  • Öztoprak F, Javed A. Case fatality rate estimation of COVID-19 for European countries: Turkey’s current scenario amidst a global pandemic; comparison of outbreaks with European countries. EJMO 2020; 4: 149-59
Toplam 24 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Konular Sağlık Kurumları Yönetimi
Bölüm Orijinal Makale
Yazarlar

İbrahim Halil İnanç 0000-0003-4046-6748

Nurbanu Bursa 0000-0003-3747-5870

Ahmet Gültepe 0000-0002-9653-8782

Cengiz Şabanoğlu 0000-0003-1163-5610

Yayımlanma Tarihi 5 Eylül 2021
Yayımlandığı Sayı Yıl 2021 Cilt: 4 Sayı: 5

Kaynak Göster

AMA İnanç İH, Bursa N, Gültepe A, Şabanoğlu C. The impact of COVID-19 on rural population: A retrospective study. J Health Sci Med /JHSM /jhsm. Eylül 2021;4(5):722-727. doi:10.32322/jhsm.957308

Üniversitelerarası Kurul (ÜAK) Eşdeğerliği:  Ulakbim TR Dizin'de olan dergilerde yayımlanan makale [10 PUAN] ve 1a, b, c hariç  uluslararası indekslerde (1d) olan dergilerde yayımlanan makale [5 PUAN]

Dahil olduğumuz İndeksler (Dizinler) ve Platformlar sayfanın en altındadır.

Not:
Dergimiz WOS indeksli değildir ve bu nedenle Q olarak sınıflandırılmamıştır.

Yüksek Öğretim Kurumu (YÖK) kriterlerine göre yağmacı/şüpheli dergiler hakkındaki kararları ile yazar aydınlatma metni ve dergi ücretlendirme politikasını tarayıcınızdan indirebilirsiniz. https://dergipark.org.tr/tr/journal/2316/file/4905/show 


Dergi Dizin ve Platformları

Dizinler; ULAKBİM TR Dizin, Index Copernicus, ICI World of Journals, DOAJ, Directory of Research Journals Indexing (DRJI), General Impact Factor, ASOS Index, WorldCat (OCLC), MIAR, EuroPub, OpenAIRE, Türkiye Citation Index, Türk Medline Index, InfoBase Index, Scilit, vs.

Platformlar; Google Scholar, CrossRef (DOI), ResearchBib, Open Access, COPE, ICMJE, NCBI, ORCID, Creative Commons vs.